A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Partnering with PINC AI™ Stanson’s clinical decision support (CDS) technology platform empowered a large health system in Missouri to significantly improve HCC coding accuracy.
The Cone Health team implemented the PINC AI™ Quality Enterprise to help with early sepsis recognition and to reduce mortality and cost.
Using data and technology to drive decisions around the right supplies, services and equipment for optimal care delivery, safety, outcomes and total cost.
St. Luke’s University Health Network tapped into the PINC AI™ technologies to gain visibility into data and access capabilities such as benchmarking.
PINC AI™ data helps fuel research with insights from more than 1,188 sites to provide data for evidence- and population-based analyses.
University Hospitals is collaborating with PAS to advance research, RWE generation and explore the development of new solutions, interventions and other healthcare initiatives.
PAS continues efforts to advance health equity and has partnered with NW Children’s Foundation (NWCF) to help strengthen and expand NWCF’s educational outreach.
The American Journal of Managed Care® |
In abstracts at ASH 2022, investigators detailed patient and financial outcomes associated with CAR T-cell therapies vs standard of care for treatment of large B-cell lymphoma.